RAPT Therapeutics Inc (RAPT)
NASDAQ
Quarter End | 12 2022 | 3 2023 | 6 2023 | 9 2023 | 12 2023 | 3 2024 | 6 2024 | 9 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
総売上 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
営業利益 | -24.43M | -31.56M | -28.36M | -33.92M | -33.22M | -32.52M | -29.33M | -19.79M |
税引前収入 | -22.95M | -29.27M | -25.28M | -31.37M | -30.88M | -30.52M | -27.66M | -18.43M |
純利益 | -22.95M | -29.27M | -25.28M | -31.37M | -30.88M | -30.52M | -27.66M | -18.43M |
優先配当 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | -22.95M | -29.27M | -25.28M | -31.37M | -30.88M | -30.52M | -27.66M | -18.43M |
EBITDA | -24.18M | -31.26M | -28.1M | -33.59M | -32.89M | -32.2M | -29.03M | -19.49M |
年末 2023年12月31日 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総売上 | 0 | 0 | 0 | 5.04M | 3.81M | 1.53M | 0 |
営業利益 | -29.33M | -36.95M | -43.63M | -53.21M | -69.21M | -85.8M | -127.06M |
税引前収入 | -29.12M | -36.15M | -42.34M | -51.9M | -69.2M | -83.84M | -116.8M |
純利益 | -29.12M | -36.15M | -43M | -52.89M | -69.2M | -83.84M | -116.8M |
優先配当 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | -5.513 | -6.858 | -1.969 | -2.135 | -2.342 | -2.448 | -3.396 |
EBIT | -29.12M | -36.15M | -42.34M | -51.9M | -69.2M | -83.84M | -116.8M |
EBITDA | -27.95M | -35.71M | -42.3M | -52.09M | -68.21M | -84.75M | -125.85M |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約